Literature DB >> 10087518

[Management of mental health and primary care. Development and evaluation of a training program based on the PLISSIT approach].

R Vauth1, M Härter, F Hohagen, C Kemmerich, J M Herrmann, G Haag, J Nolte, W Niebling, G Stadtmüller, K Fritzsche, M Berger.   

Abstract

Deficits in current approaches of psychosomatic and psychiatric education for general practitioners are reviewed. A skill-based training was developed in line with the four step counseling approach of the "PLISSIT" approach: The GP helps in first step ("permission") the patient to accept his problem and assesses informations about causing and maintaining factors of his symptomatology. In the second step he should provide information about the disorder and reverse misunderstanding and passivity (Limited Information). The GP's should develop preliminary strategies for change in the third step ("coping strategies", "symptom management", "special suggestions") and preparate the intensive phase of therapy as the last step. First results of the evaluation of the training program are presented demonstrate the effectiveness and acceptance of the education program.

Entities:  

Mesh:

Year:  1999        PMID: 10087518     DOI: 10.1007/s001150050400

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  3 in total

Review 1.  [Quality of life in dysphonia].

Authors:  F Rosanowski; E Grässel; U Hoppe; V Köllner
Journal:  HNO       Date:  2009-09       Impact factor: 1.284

2.  [Outcome of interactive training in detection and management skills for schizophrenic outpatient treatment by general practitioners].

Authors:  R Vauth; A Loh; P Sitta; C Schweiger; W Niebling
Journal:  Nervenarzt       Date:  2004-09       Impact factor: 1.214

3.  [Satisfaction of dysphonic patients with psychosomatic assessment and intervention].

Authors:  S Pülz; A Schützenberger; E Grässel; V Köllner; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2009-09       Impact factor: 1.284

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.